Clinical Trials · NCT05740488
Efficacy and Safety of Apalutamide in Combination With 89Sr as Neoadjuvant Therapy in Prostate Cancer With ≤10 Bone Metastases
- Phase
- N/A
- Recruitment status
- Unknown
- Sponsor
- Zhujiang Hospital
- Enrollment
- 30
- Start date
- Jan 2022
- Locations
- 1 site, China
- Primary endpoint
- PFS